Search

everythinglearnresearchcommunity

for

Search:↓

Systemic corticosteroids can help treat rapidly spreading vitiligo but require more research for safer use.

Topical corticosteroids are the best initial treatment for children's alopecia areata.

Generalized pustular psoriasis patients often need strong medication and careful treatment due to flare-ups and complications.

Nonsteroid treatments for alopecia areata show promise but need more high-quality research.

Laser and light therapies, especially the 308 nm excimer laser, are effective and safe for treating alopecia areata, but more research is needed.

Hair greying is caused by oxidative stress damaging hair follicles and melanocytes.

Most treatments for spondyloarthritis are safe, but monitoring and careful selection based on patient risks are important.

Finasteride and minoxidil are effective for hair regrowth, while treatments for alopecia areata have varying success and continuous treatment is necessary.

The document concludes that new treatments for skin conditions are complex but effective, including spironolactone for female hair loss and propranolol for infantile hemangiomas.

Manage vitiligo with treatments, address emotions, and use camouflage techniques.

Mast cells and CD8 T cells interact closely in skin diseases, affecting each other's behavior and contributing to conditions like psoriasis and eczema.

Light-based treatment, Photobiomodulation, shows promise for non-invasive skin therapy with few side effects.

A new psoriasis lotion called "Psorisbye" improved symptoms in a patient within one week.

Light/laser therapy can effectively increase hair density in some types of alopecia, especially androgenic alopecia and alopecia areata.

Acitretin is effective for severe skin conditions but has significant side effects and requires careful monitoring.

Imiquimod can cause rare skin side effects, some irreversible, and long-term follow-up is important for users.

New treatments for vitiligo may focus on protecting melanocyte stem cells from stress and targeting specific pathways involved in the condition.

The combination of cyclosporine and PUVA might help treat severe alopecia areata.

Some skin medications are safe during pregnancy and breastfeeding, but others can harm the baby and should be avoided.

Tranilast successfully treated a man's skin sarcoidosis when other treatments failed.

Melanocytes produce melanin; their defects cause vitiligo and hair graying, with treatments available for vitiligo.

Treatments for autoimmune hair loss have limited success and patients need emotional support and self-acceptance.

Various dermatologic treatments were effective for skin conditions like acne, rosacea, hair loss, and psoriasis from December 1986 to December 1987.

Minoxidil and finasteride treat hair loss; more research needed for other options.

Tofacitinib is somewhat effective for alopecia areata, but more research is needed on its safety and long-term effects.

Combined microneedling and minoxidil improves hair growth more than minoxidil alone.

308-nm excimer light therapy helped over a third of treatment-resistant alopecia universalis patients regrow most of their hair.

Some cosmetics and dermatological drugs can cause allergic reactions and side effects, like skin irritation and systemic issues.

Alopecia areata involves immune activation in the scalp, suggesting treatments targeting TH1, TH2, and IL-23 pathways.

No single treatment is consistently effective for alopecia areata, and more research is needed.